Skip to main content

WEISER DIPLOMACY CENTER

Breadcrumb

Home
EpiPen maker Mylan, Pfizer's Upjohn off-patent drug business to merge

EpiPen maker Mylan, Pfizer's Upjohn off-patent drug business to merge

August 20, 2019 USA Today

Marianne Udow-Phillips

Share:

Interdisciplinary expertise, right to your inbox.

Sign up for information about news and events from the Ford School.

Sign up

Event announcements